Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Approval of Western Herbs as OTC Drugs Becoming Reality: JSMI
March 5, 2007
- SELF-MEDICATION NEWS IN BRIEF
March 5, 2007
- TOPIC about Novo Nordisk Pharma
February 26, 2007
- SEMINAR
February 26, 2007
- Pfizer J-GAP Survey
February 26, 2007
- Regulatory Systems in Japan Need Improvements in 5 Areas: Mr Dunoyer of EFPIA Japan
February 26, 2007
- DSP Is Seeing Synergistic Effects: President Miyatake
February 26, 2007
- New Review, Consultation Fees Proposed
February 26, 2007
- Toxicogenomics Research Project
February 26, 2007
- CMIC to Go to the West to Promote Japan-Centered Clinical Trials
February 26, 2007
- R&D NEWS IN BRIEF
February 26, 2007
- Roche Diagnostics Aims for 7.1% Growth in Sales in Bearish Market
February 26, 2007
- 13 Medical Devices Selected for Priority Review
February 26, 2007
- MEDICAL DEVICE NEWS IN BRIEF
February 26, 2007
- Korosho Again Calls For Early Price Settlement
February 26, 2007
- Daiichi Sankyo Gears Up to Become Global Drug Discovery Company
February 26, 2007
- REGULATORY NEWS IN BRIEF
February 26, 2007
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
February 26, 2007
- OTC Drugs That Meet Today's Needs Are Necessary: Mr Kurokawa
February 26, 2007
- NEW PRODUCT
February 26, 2007
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…